Initial studies geared toward therapy showed that siRNAs and antisense oligonucleotides targeting the DUX4 PAS and mRNA splice sites reduced levels of DUX4-fl mRNA and protein in FSHD myotubes [60,61]. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.